Insulin Resistance: A Proinflammatory State Mediated by Lipid-Induced Signaling Dysfunction and Involved in Atherosclerotic Plaque Instability

The dysregulation of the insulin-glucose axis represents the crucial event in insulin resistance syndrome. Insulin resistance increases atherogenesis and atherosclerotic plaque instability by inducing proinflammatory activities on vascular and immune cells. This condition characterizes several disea...

Full description

Saved in:
Bibliographic Details
Main Authors: Fabrizio Montecucco, Sabine Steffens, François Mach
Format: Article
Language:English
Published: Wiley 2008-01-01
Series:Mediators of Inflammation
Online Access:http://dx.doi.org/10.1155/2008/767623
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832548545471709184
author Fabrizio Montecucco
Sabine Steffens
François Mach
author_facet Fabrizio Montecucco
Sabine Steffens
François Mach
author_sort Fabrizio Montecucco
collection DOAJ
description The dysregulation of the insulin-glucose axis represents the crucial event in insulin resistance syndrome. Insulin resistance increases atherogenesis and atherosclerotic plaque instability by inducing proinflammatory activities on vascular and immune cells. This condition characterizes several diseases, such as type 2 diabetes, impaired glucose tolerance (IGT), impaired fasting glucose (IFG), obesity, hypertension, dyslipidemia, and other endocrinopathies, but also cancer. Recent studies suggest that the pathophysiology of insulin resistance is closely related to interferences with insulin-mediated intracellular signaling on skeletal muscle cells, hepatocytes, and adipocytes. Strong evidence supports the role of free fatty acids (FFAs) in promoting insulin resistance. The FFA-induced activation of protein kinase C (PKC) delta, inhibitor kappaB kinase (IKK), or c-Jun N-terminal kinase (JNK) modulates insulin-triggered intracellular pathway (classically known as PI3-K-dependent). Therefore, reduction of FFA levels represents a selective target for modulating insulin resistance.
format Article
id doaj-art-6df1c02b325e44a6999b4057951eb0d0
institution Kabale University
issn 0962-9351
1466-1861
language English
publishDate 2008-01-01
publisher Wiley
record_format Article
series Mediators of Inflammation
spelling doaj-art-6df1c02b325e44a6999b4057951eb0d02025-02-03T06:13:48ZengWileyMediators of Inflammation0962-93511466-18612008-01-01200810.1155/2008/767623767623Insulin Resistance: A Proinflammatory State Mediated by Lipid-Induced Signaling Dysfunction and Involved in Atherosclerotic Plaque InstabilityFabrizio Montecucco0Sabine Steffens1François Mach2Division of Cardiology, Foundation for Medical Researches, University Hospital, 1211 Geneva, SwitzerlandDivision of Cardiology, Foundation for Medical Researches, University Hospital, 1211 Geneva, SwitzerlandDivision of Cardiology, Foundation for Medical Researches, University Hospital, 1211 Geneva, SwitzerlandThe dysregulation of the insulin-glucose axis represents the crucial event in insulin resistance syndrome. Insulin resistance increases atherogenesis and atherosclerotic plaque instability by inducing proinflammatory activities on vascular and immune cells. This condition characterizes several diseases, such as type 2 diabetes, impaired glucose tolerance (IGT), impaired fasting glucose (IFG), obesity, hypertension, dyslipidemia, and other endocrinopathies, but also cancer. Recent studies suggest that the pathophysiology of insulin resistance is closely related to interferences with insulin-mediated intracellular signaling on skeletal muscle cells, hepatocytes, and adipocytes. Strong evidence supports the role of free fatty acids (FFAs) in promoting insulin resistance. The FFA-induced activation of protein kinase C (PKC) delta, inhibitor kappaB kinase (IKK), or c-Jun N-terminal kinase (JNK) modulates insulin-triggered intracellular pathway (classically known as PI3-K-dependent). Therefore, reduction of FFA levels represents a selective target for modulating insulin resistance.http://dx.doi.org/10.1155/2008/767623
spellingShingle Fabrizio Montecucco
Sabine Steffens
François Mach
Insulin Resistance: A Proinflammatory State Mediated by Lipid-Induced Signaling Dysfunction and Involved in Atherosclerotic Plaque Instability
Mediators of Inflammation
title Insulin Resistance: A Proinflammatory State Mediated by Lipid-Induced Signaling Dysfunction and Involved in Atherosclerotic Plaque Instability
title_full Insulin Resistance: A Proinflammatory State Mediated by Lipid-Induced Signaling Dysfunction and Involved in Atherosclerotic Plaque Instability
title_fullStr Insulin Resistance: A Proinflammatory State Mediated by Lipid-Induced Signaling Dysfunction and Involved in Atherosclerotic Plaque Instability
title_full_unstemmed Insulin Resistance: A Proinflammatory State Mediated by Lipid-Induced Signaling Dysfunction and Involved in Atherosclerotic Plaque Instability
title_short Insulin Resistance: A Proinflammatory State Mediated by Lipid-Induced Signaling Dysfunction and Involved in Atherosclerotic Plaque Instability
title_sort insulin resistance a proinflammatory state mediated by lipid induced signaling dysfunction and involved in atherosclerotic plaque instability
url http://dx.doi.org/10.1155/2008/767623
work_keys_str_mv AT fabriziomontecucco insulinresistanceaproinflammatorystatemediatedbylipidinducedsignalingdysfunctionandinvolvedinatheroscleroticplaqueinstability
AT sabinesteffens insulinresistanceaproinflammatorystatemediatedbylipidinducedsignalingdysfunctionandinvolvedinatheroscleroticplaqueinstability
AT francoismach insulinresistanceaproinflammatorystatemediatedbylipidinducedsignalingdysfunctionandinvolvedinatheroscleroticplaqueinstability